Gastro-oesophageal Reflux Disease Trial, Recruiting NCT07158008 Sponsor: Jagiellonian University Condition: Gastro-oesophageal Reflux Disease
Back to Gord

Gastro-oesophageal Reflux Disease Trial, Recruiting

NCT07158008
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the N-Sleeve Gastrectomy or Gastric Bypass groups:

  • People who are 18 years of age or older
  • People who are willing and able to provide written consent to participate
  • People whose body weight meets national guidelines for weight-loss surgery — specifically, a BMI of 40 or above, or a BMI of 35 or above alongside other health conditions related to obesity
  • People who have ongoing acid reflux symptoms, shown by at least one of the following: regular use of acid-blocking medication (called PPIs), a reflux symptom questionnaire score above 6 (GerdQ), or a camera examination of the food pipe showing signs of irritation rated Grade B or higher

For the Sleeve Gastrectomy observation group:

  • People who are 18 years of age or older
  • People who are willing and able to provide written consent to participate
  • People whose body weight meets national guidelines for weight-loss surgery — specifically, a BMI of 40 or above, or a BMI of 35 or above alongside other health conditions related to obesity
  • People who have no symptoms and no history of acid reflux disease

Who may not be able to join:

  • People who have previously had surgery to treat acid reflux
  • People who have had any prior surgery on the upper part of the digestive tract (stomach, oesophagus, or nearby areas)
  • People who currently smoke or have a history of nicotine use
  • People with serious heart failure classified as severe by medical standards (confirm with trial site)
  • People who are pregnant or planning to become pregnant during the study period
  • People whose overall health situation, in the opinion of the medical team running the trial, could make it difficult to safely follow the study's requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0048124002600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jagiellonian University
Registry
ClinicalTrials.gov
Start date
31 July 2025
Est. completion
31 July 2028

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

GERD Symptom Remission

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov